Cargando…
The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
Great advances have been made in describing the intracellular pathways and genes that are activated by bacterial products. New definitions and therapies for sepsis will be based on such cellular and genetic alterations. In particular, in 2051 sepsis will no longer be defined simply as a clinical con...
Autor principal: | Abraham, Edward |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137301/ https://www.ncbi.nlm.nih.gov/pubmed/12225594 |
Ejemplares similares
-
The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
por: Marshall, John C
Publicado: (2002) -
The International Sepsis Forum's controversies in sepsis: corticosteroids should be used to treat septic shock
por: Goodman, Sergey, et al.
Publicado: (2002) -
The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
por: Bernard, Gordon
Publicado: (2002) -
The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
por: Sharma, Vinay K, et al.
Publicado: (2003) -
The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrine
por: Vincent, Jean-Louis, et al.
Publicado: (2003)